gamma-aminobutyric acid has been researched along with Cranial Nerve II Diseases in 1 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crofts, K | 1 |
| Brennan, R | 1 |
| Kearney, P | 1 |
| O'Connor, G | 1 |
1 other study available for gamma-aminobutyric acid and Cranial Nerve II Diseases
| Article | Year |
|---|---|
Vigabatrin-induced optic neuropathy.
Topics: Anticonvulsants; Child; Female; gamma-Aminobutyric Acid; Humans; Optic Nerve Diseases; Vigabatrin | 1997 |